Trial tests have been carried out on the new COVID-19 VACCINE in OXFORD UNIVERSITY and it is estimated that around 1,007 patients have taken a shot of the vaccine. It is believed that the vaccine yielded a positive stance as it led to the formation of Antibodies and T-Cells that helps the body fight against the CORONAVIRUS.
The UK vaccine has shone rays of hope and it has been ordered that 100million doses be formulated so as to prove the credibility of the vaccine.
The vaccine known as ChAdOx1 nCoV-19 is being developed at an unrivaled rate. It is gotten from a genetically engineered virus that causes Cold in Chimpanzees.
The vaccine however has been stated to have mild side effects on 70% of those who were placed on it, they developed mild headaches and fever, but researchers already stated Paracetamol as relief material.
Prof Sarah Gilbert, from the University of Oxford, UK, says: “There is still much work to be done before we can confirm if our vaccine will help manage the Covid-19 pandemic, but these early results hold promise”
More than 10,000 people would be treated with the vaccine in it’s next trying phase and this is mainly to ensure its authenticity. The trial phase has been extended to other countries due to the low confirmed rates of the virus in the UK.
There will be a large trial involving 30,000 people in the US as well as 2,000 in South Africa and 5,000 in Brazil. The widespread of the vaccine has been estimated to be in the early next year.
Boris Johnson said: “Obviously I’m hopeful, I’ve got my fingers crossed, but to say I’m 100% confident we’ll get a vaccine this year, or indeed next year, is, alas, just an exaggeration.”
However, the UK vaccine has not been proven to be effective.